Ligand Pharmaceuticals reported $438K in Interest Expense on Debt for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Agenus AGEN:US USD 15.61M 1.88M
Amgen AMGN:US USD 368M 40M
Baxter International BAX:US USD 109M 16M
Bristol Myers Squibb BMY:US USD 299M 14M
Clovis Oncology CLVS:US USD 9.86M 189K
Eli Lilly And LLY:US USD 81.5M 300K
Endo International Ordinary Shares ENDP:US USD 74.93M 65M
Gilead Sciences GILD:US USD 229M 13M
Harsco HSC:US USD 19.75M 3.06M
Immunogen IMGN:US USD 867K 211K
Insmed INSM:US USD 3.35M 4K
Intrexon XON:US USD 2.04M 27K
Karyopharm Therapeutics KPTI:US USD 6.11M 199K
Lannett LCI:US USD 15.03M 222K
Pacira Pharmaceuticals PCRX:US USD 9.86M 1.02M
Pfizer PFE:US USD 311M 18M
Teva Pharmaceutical Industries TEVA:US USD 230M 5M
Veracyte VCYT:US USD 61K 9K